Progyny Inc Revenue per Employee (PGNY), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Progyny Inc   (NASDAQ: PGNY)
    Sector • Healthcare    Industry • Healthcare Facilities
   Industry • Healthcare Facilities
   Sector • Healthcare
 

Progyny Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 5.58% in the second quarter 2026, year on year to cumulative value of $1,311 million, Progyny Inc 's revenue per employee grew on a trailing twelve months basis to $ 1,531,890, this marks a new company high.
Within the Healthcare sector Employees of 52 other companies have achieved higher revenue per employee. While Progyny Inc 's total ranking has deteriorated compared to the previous quarter from 489 to 576. Progyny Inc has 856 employees.


What is Sales per Employee Ratio?






Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

PGNY Revenue per Employee (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter		 (Jun 30 2025)
II. Quarter
Y / Y Revenue Change 5.58 % 1.32 % 6.83 % 9.29 % 9.46 %
Sales per Employee (TTM) $ 1,531,890 1,510,234 1,505,238 1,481,349 1,450,285
PGNY's Total Ranking # 576 # 489 # 130 # 82 # 136
Seq. Revenue Change 6.84 % 2.56 % 2.25 % -5.76 % 2.53 %

PGNY Company Profile >> Back to PGNY Efficiency Comparisons >> Compare PGNY Sales per Employee to its Competitors

Revenue per Employee Company Ranking
Within: No.
Healthcare Facilities Industry # 3
Healthcare Sector # 53
Overall Market # 576

Revenue per Employee Statistics
High Average Low
$ 1,531,890 $ 976,855 $ 71,491
(Jun 30 2026)   (Sep 30 2019)



Financial Statements
Progyny Inc 's Revenue MRQ $ 351 Millions Visit PGNY's Income Statement
Progyny Inc 's Revenues TTM $ 1,311 Millions Visit PGNY's aggregate revenue growth
What are PGNY's Sales? Visit PGNY's Sales by Segment




Other Ratios
Progyny Inc 's Income per Employee
Employees in Healthcare Facilities
Healthcare Facilities Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
PGNY's Revenue per Employee versus Healthcare Facilities Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for PGNY's Competitors
Revenue per Employee for PGNY's Suppliers
Revenue per Employee for PGNY's Customers

You may also want to know
PGNY's Sales Growth Rates PGNY's Pe Price to earnings ratio PGNY's Receivables Turnover Ratio PGNY's Stock Quote
PGNY's Net Income Growth Rates PGNY's Ps Price to Sales ratio PGNY's Sales per Employee PGNY's Asset Turnover Ratio
PGNY's Net Margin PGNY's Pb Price to Book ratio PGNY's Financial Strength Ratios PGNY's Dividend Payout Ratio
Date modified: 2026-08-14T20:54:24+00:00




Companies with similar Revenue per Employee for 12 months ending Jun 30 2026, within Healthcare Sector Revenue per Employee Revenue 12 months ending Jun 30 2026Number of Employees Jun 30 2026
Innoviva Inc   2,645,471.70 $ 420.630  Million 159 
Aurinia Pharmaceuticals Inc   2,433,648.44 $ 311.507  Million 128 
Eton Pharmaceuticals Inc   2,392,704.55 $ 105.279  Million 44 
Cormedix Inc   2,366,196.28 $ 451.943  Million 191 
Sarepta Therapeutics Inc   2,364,483.83 $ 1,974.344  Million 835 
United Therapeutics Corporation  2,253,214.29 $ 3,154.500  Million 1,400 
Biocryst Pharmaceuticals Inc   2,162,328.74 $ 940.613  Million 435 
Elite Pharmaceuticals Inc   2,155,839.86 $ 140.130  Million 65 
Protagonist Therapeutics inc   2,136,303.03 $ 281.992  Million 132 
Exelixis Inc   2,123,731.47 $ 2,435.920  Million 1,147 
Zevra Therapeutics Inc   2,112,377.05 $ 128.855  Million 61 
Liquidia Corporation  2,087,532.41 $ 450.907  Million 216 
Tg Therapeutics Inc   2,003,849.62 $ 799.536  Million 399 
Prestige Consumer Healthcare Inc   1,938,521.05 $ 1,104.957  Million 570 
Privia Health Group Inc   1,923,384.18 $ 2,358.069  Million 1,226 
Alnylam Pharmaceuticals Inc   1,921,672.80 $ 4,804.182  Million 2,500 
Gilead Sciences Inc   1,791,588.24 $ 30,457.000  Million 17,000 
Collegium Pharmaceutical Inc   1,777,172.58 $ 751.744  Million 423 
Fennec Pharmaceuticals Inc   1,692,028.57 $ 59.221  Million 35 
Neurocrine Biosciences Inc   1,686,950.00 $ 3,373.900  Million 2,000 
Mirum Pharmaceuticals Inc   1,661,470.43 $ 618.067  Million 372 
Tarsus Pharmaceuticals Inc   1,638,732.43 $ 606.331  Million 370 
Agenus Inc  1,638,185.19 $ 132.693  Million 81 
Xenetic Biosciences Inc   1,630,388.50 $ 3.261  Million 2 
Ideaya Biosciences Inc   1,614,668.97 $ 234.127  Million 145 
Eli Lilly And Company  1,593,316.00 $ 79,665.800  Million 50,000 
Jazz Pharmaceuticals Plc  1,592,122.15 $ 4,601.233  Million 2,890 
Rigel Pharmaceuticals Inc  1,590,718.39 $ 276.785  Million 174 
Progyny Inc   1,531,890.19 $ 1,311.298  Million 856 
Bristol myers Squibb Company  1,513,415.38 $ 49,186.000  Million 32,500 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.